pharMEDium Pharmaceuticals IPO Research Information

pharMEDium Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on pharMEDium Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
pharMEDium Pharmaceuticals	PMHC - NYSE	TBD	$0.00	$0.00	TBD
Underwriter(s): Credit Suisse, J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Goldman Sachs & Co.
Co-Manager(s): Baird
Industry:
Filing(s): FIled 2015-08-31

About pharMEDium Pharmaceuticals (adapted from pharMEDium Pharmaceuticals prospectus):
They are the leading national provider of outsourced compounded sterile preparations, or CSPs, to acute care hospitals in the United States.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "PMHC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.